AVLIX | DOXGX | AVLIX / DOXGX | |
Total Expense Ratio | 0.79 | 0.41 | 193% |
Annual Report Gross Expense Ratio | 0.82 | 0.46 | 178% |
Fund Existence | 28 years | 3 years | - |
Gain YTD | 6.963 | 7.699 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 2500 | 200,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.17B | 114B | 2% |
Annual Yield % from dividends | 1.94 | 1.47 | 132% |
Returns for 1 year | 4.61 | 8.43 | 55% |
Returns for 3 years | 5.85 | 32.25 | 18% |
Returns for 5 years | 33.95 | N/A | - |
Returns for 10 years | 16.50 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OEGYX | 34.80 | 0.40 | +1.16% |
Invesco Discovery Mid Cap Growth Y | |||
FCUCX | 19.66 | 0.17 | +0.87% |
NYLI PineStone U.S. Equity Class C | |||
PMDDX | 18.83 | 0.07 | +0.37% |
Principal Small-MidCap Dividend Inc C | |||
SVXAX | 63.56 | 0.14 | +0.22% |
Smead International Value A | |||
TRXAX | 12.22 | N/A | N/A |
Catalyst/MAP Global Balanced A |